Aragona, C.; Bezerra Espinola, M.S.; Bilotta, G.; Porcaro, G.; Calcagno, M.
Evaluating the Efficacy of Pervistop®, a New Combination Based on EGCG, Folic Acid, Vitamin B12 and Hyaluronic Acid on Patients with Human Papilloma Virus (HPV) Persistent Infections and Cervical Lesions: A Pilot Study. J. Clin. Med. 2023, 12, 2171.
https://doi.org/10.3390/jcm12062171
AMA Style
Aragona C, Bezerra Espinola MS, Bilotta G, Porcaro G, Calcagno M.
Evaluating the Efficacy of Pervistop®, a New Combination Based on EGCG, Folic Acid, Vitamin B12 and Hyaluronic Acid on Patients with Human Papilloma Virus (HPV) Persistent Infections and Cervical Lesions: A Pilot Study. Journal of Clinical Medicine. 2023; 12(6):2171.
https://doi.org/10.3390/jcm12062171
Chicago/Turabian Style
Aragona, Cesare, Maria Salomè Bezerra Espinola, Gabriele Bilotta, Giuseppina Porcaro, and Marco Calcagno.
2023. "Evaluating the Efficacy of Pervistop®, a New Combination Based on EGCG, Folic Acid, Vitamin B12 and Hyaluronic Acid on Patients with Human Papilloma Virus (HPV) Persistent Infections and Cervical Lesions: A Pilot Study" Journal of Clinical Medicine 12, no. 6: 2171.
https://doi.org/10.3390/jcm12062171
APA Style
Aragona, C., Bezerra Espinola, M. S., Bilotta, G., Porcaro, G., & Calcagno, M.
(2023). Evaluating the Efficacy of Pervistop®, a New Combination Based on EGCG, Folic Acid, Vitamin B12 and Hyaluronic Acid on Patients with Human Papilloma Virus (HPV) Persistent Infections and Cervical Lesions: A Pilot Study. Journal of Clinical Medicine, 12(6), 2171.
https://doi.org/10.3390/jcm12062171